These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 29322178

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Diagnosis of sporadic neurofibromatosis type 2 in the paediatric population.
    Anand G, Vasallo G, Spanou M, Thomas S, Pike M, Kariyawasam DS, Mehta S, Parry A, Durie-Gair J, Nicholson J, Lascelles K, Everett V, Gibbon FM, Jarvis N, Elston J, Evans DG, Halliday D.
    Arch Dis Child; 2018 May; 103(5):463-469. PubMed ID: 29535107
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of NF2 and NF1 tumor suppressor genes in distinctive gastrointestinal nerve sheath tumors traditionally diagnosed as benign schwannomas: s study of 20 cases.
    Lasota J, Wasag B, Dansonka-Mieszkowska A, Karcz D, Millward CL, Ryś J, Stachura J, Sobin LH, Miettinen M.
    Lab Invest; 2003 Sep; 83(9):1361-71. PubMed ID: 13679444
    [Abstract] [Full Text] [Related]

  • 26. [Type 2 neurofibromatosis: intergenerational differences in genetic and clinical expression].
    Drouet A, Le Moigne F, Salamé D, Quesnel L, Motolese C, des Portes V, Guilloton L, Pinson S.
    Arch Pediatr; 2014 Nov; 21(11):1233-40. PubMed ID: 25439059
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Updated protocol for genetic testing, screening and clinical management of individuals at risk of NF2-related schwannomatosis.
    Halliday D, Emmanouil B, Evans DGR.
    Clin Genet; 2023 May; 103(5):540-552. PubMed ID: 36762955
    [Abstract] [Full Text] [Related]

  • 30. A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene.
    Bruder CE, Ichimura K, Tingby O, Hirakawa K, Komatsuzaki A, Tamura A, Yuasa Y, Collins VP, Dumanski JP.
    Hum Genet; 1999 May; 104(5):418-24. PubMed ID: 10394935
    [Abstract] [Full Text] [Related]

  • 31. Isolation and characterization of Schwann cells from neurofibromatosis type 2 patients.
    Rosenbaum C, Kluwe L, Mautner VF, Friedrich RE, Müller HW, Hanemann CO.
    Neurobiol Dis; 1998 Jul; 5(1):55-64. PubMed ID: 9702788
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Paediatric presentation of type 2 neurofibromatosis.
    Evans DG, Birch JM, Ramsden RT.
    Arch Dis Child; 1999 Dec; 81(6):496-9. PubMed ID: 10569966
    [Abstract] [Full Text] [Related]

  • 35. Laryngeal plexiform schwannoma as first symptom in a patient with neurofibromatosis type 2.
    Nagato T, Katada A, Yoshizaki T, Kunibe I, Takahara M, Katayama A, Hayashi T, Harabuchi Y.
    Clin Neurol Neurosurg; 2010 Jul; 112(6):505-8. PubMed ID: 20303213
    [Abstract] [Full Text] [Related]

  • 36. Cellular mechanisms of heterogeneity in NF2-mutant schwannoma.
    Chiasson-MacKenzie C, Vitte J, Liu CH, Wright EA, Flynn EA, Stott SL, Giovannini M, McClatchey AI.
    Nat Commun; 2023 Mar 21; 14(1):1559. PubMed ID: 36944680
    [Abstract] [Full Text] [Related]

  • 37. Genetic Counseling for Neurofibromatosis 1, Neurofibromatosis 2, and Schwannomatosis-Practice Resource of the National Society of Genetic Counselors.
    Radtke HB, Bergner AL, Goetsch AL, McGowan C, Panzer K, Cannon A.
    J Genet Couns; 2020 Oct 21; 29(5):692-714. PubMed ID: 32602153
    [Abstract] [Full Text] [Related]

  • 38. Somatic Mosaicism of NF2 Gene Mutation with Constitutional NF1 Gene Mutation in Neurofibromatosis Type 2: a Case Report.
    Yoo SJ, Hwang YS.
    Clin Lab; 2020 Nov 01; 66(11):. PubMed ID: 33180429
    [Abstract] [Full Text] [Related]

  • 39. Neurofibromatosis 2 in children presenting during the first decade of life.
    Gaudioso C, Listernick R, Fisher MJ, Campen CJ, Paz A, Gutmann DH.
    Neurology; 2019 Sep 03; 93(10):e964-e967. PubMed ID: 31363058
    [Abstract] [Full Text] [Related]

  • 40. A 163-bp deletion in the neurofibromatosis 2 (NF2) gene associated with variant phenotypes [corrected].
    Kluwe L, Pulst SM, Köppen J, Mautner VF.
    Hum Genet; 1995 Apr 03; 95(4):443-6. PubMed ID: 7705843
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.